AC IMMUNE SA (ACIU)

CH0329023102 - Common Stock

2.39  -0.05 (-2.05%)

After market: 2.46 +0.07 (+2.93%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
14.80M3.90M0.0015.40M110.50M
Operating Expenses
68.42M74.80M79.00M76.70M65.90M
Research and Development
54.61M60.30M62.30M59.50M50.40M
Selling, General, and Administrative Expenses
10.58M9.60M10.90M11.10M9.40M
Operating Income
-53.62M-70.80M-79.00M-61.30M44.50M
Interest Income/Expense
-599.00K100.00K6.00M-700.00K-3.60M
Other Income/Expense
N/AN/A0.000.004.50M
Income Before Taxes
-54.22M-70.70M-73.00M-61.90M45.40M
Income Tax
10.00K0.000.000.000.00
Net Income
-54.23M-70.80M-73.00M-61.90M45.40M
EBITDA
-51.41M-68.44M-76.59M-59.33M46.19M
 
Per Share Data
EPS Diluted Total Ops
-0.64-0.85-0.97-0.860.64
Non GAAP EPS
-0.64-0.85-0.99-0.840.69
 
Statistics
Profit Margin
-366.41%-1815.38%N/A-401.95%41.09%
Operating Profit Margin
-362.30%-1815.38%N/A-398.05%40.27%

All data in CHF

Charts